MEDCast cover art

MEDCast

MEDCast

Written by: MJH Life Sciences
Listen for free

About this listen

 MEDCast is a healthcare program brought to you by HCPLive.com that features leading medical experts who discuss a range topic within a particular condition or medical disorder.© Biological Sciences Hygiene & Healthy Living Nature & Ecology Physical Illness & Disease Science
Episodes
  • 6: Expanding Options in mHSPC: What the Latest FDA Approval Means for Clinical Practice

    6: Expanding Options in mHSPC: What the Latest FDA Approval Means for Clinical Practice
    Dec 3 2025
    Panelists discuss how the recent FDA approval of darolutamide for metastatic hormone-sensitive prostate cancer (mHSPC) expands treatment options, offering improved tolerability with lower fatigue rates and fewer central nervous system adverse effects than other androgen pathway inhibitors, while exploring considerations for patient selection, trial design interpretation, and the evolving role of real-world evidence in clinical decision-making.
    Show More Show Less
    39 mins
  • 4: Pharmacists at the Forefront: Advancing Care for Patients with ROS1+ NSCLC

    4: Pharmacists at the Forefront: Advancing Care for Patients with ROS1+ NSCLC
    Oct 15 2025
    This video explores the evolving treatment landscape for ROS1-positive non-small cell lung cancer (NSCLC), focusing on targeted therapies, clinical evidence for repotrectinib, management of adverse events, and the pharmacist’s role in improving patient care and adherence.
    Show More Show Less
    1 hr and 3 mins
  • 3: Pharmacists at the Forefront: Advancing Care for Patients with ROS1+ NSCLC

    3: Pharmacists at the Forefront: Advancing Care for Patients with ROS1+ NSCLC
    Oct 15 2025
    1 hr and 3 mins
No reviews yet